Thu, August 18, 2022
Wed, August 17, 2022
Tue, August 16, 2022
Mon, August 15, 2022
Fri, August 12, 2022
Thu, August 11, 2022

Raghuram Selvaraju Maintained (SPRO) at Strong Buy with Decreased Target to $7 on, Aug 15th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-7-on-aug-15th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Spero Therapeutics, Inc." (SPRO) at Strong Buy with Decreased Target from $10 to $7 on, Aug 15th, 2022.

Raghuram has made no other calls on SPRO in the last 4 months.



There are 4 other peers that have a rating on SPRO. Out of the 4 peers that are also analyzing SPRO, 3 agree with Raghuram's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Esther Hong of "Berenberg" Downgraded from Strong Buy to Hold and Held Target at $2 on, Friday, May 20th, 2022
  • Ritu Baral of "Cowen & Co." Downgraded from Buy to Hold on, Wednesday, May 4th, 2022
  • Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold and Decreased Target to $2 on, Wednesday, May 4th, 2022


This is the rating of the analyst that currently disagrees with Raghuram


  • Louise Chen of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $5 on, Tuesday, May 17th, 2022

Publication Contributing Sources